Sylvie Jorieux

Person

Villeneuve D'Ascq, FR

People

Patents Grantslast 30 patents

Information Patent Grant
Use of ADCC-optimized antibodies for treating low-responder patients
- Patent number 9,879,089
- Issue date Jan 30, 2018
- LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Dominique Bourel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Optimized FC variants
- Patent number RE46585
- Issue date Oct 24, 2017
- LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Christian Behrens
Information Patent Grant
Optimized FC variants
- Patent number RE45992
- Issue date May 3, 2016
- LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Christian Behrens
- 001 -
Information Patent Grant
Use of ADCC-optimized antibodies for treating weak patients
- Patent number 9,109,020
- Issue date Aug 18, 2015
- LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Dominique Bourel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Optimized FC variants
- Patent number 8,742,074
- Issue date Jun 3, 2014
- LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Christian Behrens
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of ADCC-optimized antibodies for treating weak patients
- Patent number 8,501,171
- Issue date Aug 6, 2013
- LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Dominique Bourel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-rhesus D monoclonal antibody
- Patent number 8,404,241
- Issue date Mar 26, 2013
- LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Christine Gaucher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of ADCC-optimized antibodies for treating low-responder patients
- Patent number 7,713,524
- Issue date May 11, 2010
- LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Dominique Bourel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
FACTOR H FRAGMENT FOR USE AS AN ANTI-ANGIOGENIC AGENT
- Publication number 20190388506
- Publication date Dec 26, 2019
- Inserm (institut National de la Sante et de la Recherche Medicale)
- Virginie DINET
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF ADCC-OPTIMIZED ANTIBODIES FOR TREATING WEAK PATIENTS
- Publication number 20150307624
- Publication date Oct 29, 2015
- LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Dominique Bourel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FC VARIANTS WITH REDUCED EFFECTOR FUNCTIONS
- Publication number 20140378663
- Publication date Dec 25, 2014
- LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DE BIOTECHNOLOGIES
- Alexandre Fontayne
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF ADCC-OPTIMIZED ANTIBODIES FOR TREATING WEAK PATIENTS
- Publication number 20140017243
- Publication date Jan 16, 2014
- Dominique Bourel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OPTIMIZED FC VARIANTS
- Publication number 20120009188
- Publication date Jan 12, 2012
- LFB Biotechnologies
- Christian Behrens
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-RHESUS D MONOCLONAL ANTIBODY
- Publication number 20110311556
- Publication date Dec 22, 2011
- LFB Biotechnologies
- Christine Gaucher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of ADCC-Optimized antibodies for treating weak patients
- Publication number 20100303826
- Publication date Dec 2, 2010
- LFB BIOTECHNOLOGIES
- Dominique Bourel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF PATHOLOGIES WHICH ESCAPE THE IMMUNE RESPONSE, USING OP...
- Publication number 20090081216
- Publication date Mar 26, 2009
- LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Christophe de Romeuf
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD FOR PREPARING ANTIBODIES SELECTIVE FOR ACTIVATING FC RECEPTORS
- Publication number 20090029393
- Publication date Jan 29, 2009
- LFB Biotechnologies
- Jean-Luc Teillaud
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel lgG3 Antibodies for Stimulating Phagocytosis
- Publication number 20070218052
- Publication date Sep 20, 2007
- Labopratoire Francais du Fractionnement et des Biotechnologies
- Christophe De Romeuf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Correlation between the fucose content/galactose content ratio of a...
- Publication number 20070015239
- Publication date Jan 18, 2007
- LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Nicolas Bihoreau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of adcc-optimized antibodies for treating weak patients
- Publication number 20060182741
- Publication date Aug 17, 2006
- LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Dominique Bourel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of pathologies which escape the immune response, using op...
- Publication number 20050271652
- Publication date Dec 8, 2005
- LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Christophe de Romeuf
- C07 - ORGANIC CHEMISTRY

Sylvie Jorieux

Person

Patents Grantslast 30 patents

Use of ADCC-optimized antibodies for treating low-responder patients

Optimized FC variants

Optimized FC variants

Use of ADCC-optimized antibodies for treating weak patients

Optimized FC variants

Use of ADCC-optimized antibodies for treating weak patients

Anti-rhesus D monoclonal antibody

Use of ADCC-optimized antibodies for treating low-responder patients

Patents Applicationslast 30 patents

FACTOR H FRAGMENT FOR USE AS AN ANTI-ANGIOGENIC AGENT

USE OF ADCC-OPTIMIZED ANTIBODIES FOR TREATING WEAK PATIENTS

FC VARIANTS WITH REDUCED EFFECTOR FUNCTIONS

USE OF ADCC-OPTIMIZED ANTIBODIES FOR TREATING WEAK PATIENTS

OPTIMIZED FC VARIANTS

ANTI-RHESUS D MONOCLONAL ANTIBODY

Use of ADCC-Optimized antibodies for treating weak patients

TREATMENT OF PATHOLOGIES WHICH ESCAPE THE IMMUNE RESPONSE, USING OP...

METHOD FOR PREPARING ANTIBODIES SELECTIVE FOR ACTIVATING FC RECEPTORS

Novel lgG3 Antibodies for Stimulating Phagocytosis

Correlation between the fucose content/galactose content ratio of a...

Use of adcc-optimized antibodies for treating weak patients

Treatment of pathologies which escape the immune response, using op...